Success

Alert

Please select a Day.

Info

Dr Reddys Laboratories Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

Have a query? Talk to Experts LIVE

Follow Following

Score

87/100

1,277.60

-3.00 (-0.23%)

As on 16 Dec, 2025 | 09:06

Open Trading A/c

Day Range

0.00

L H

52 Week Range

1020.00

1405.90

L H

Volume

670

* BSE Market Depth (15 Dec 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
10	1280.00	1280.50	10
500	1277.40	1280.55	37
2	1277.20	1280.90	43
503	1277.00	1280.95	116
188	1276.85	1281.00	2297
0	Total	Total	0

Bid / Ask

1280.00 / 1280.95

Advance Chart

Score

87/100

1,280.00

-0.40 (-0.03%)

As on 16 Dec, 2025 | 09:05

Open Trading A/c

Day Range

0.00

L H

52 Week Range

1025.90

1404.60

L H

Volume

* BSE Market Depth (15 Dec 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
10	1280.00	1280.50	10
500	1277.40	1280.55	37
2	1277.20	1280.90	43
503	1277.00	1280.95	116
188	1276.85	1281.00	2297
0	Total	Total	0

Bid / Ask

1280.00 / 1280.95

Advance Chart

Score

87/100

-- (--%)

As on --

Day Range

L H

Open Interest Analysis

Long Unwinding

(OI , PRICE )

See Historical Trend

Volume

Bid / Ask

Advance Chart

Score

87/100

-- (--%)

As on --

Day Range

L H

Moneyness

Volume

Bid / Ask

Advance Chart

Dr Reddys Labs

1,277.60

-3.00(-0.23%)

NSE

#KnowBeforeYouInvest
Forecast

MC Essentials

76% Pass

MC Technicals

This represents current trend.Click here for disclaimer.

Trend

MC Insights

Superior Financial Strength, High Growth Trend Stock at Attractive Valuations

Financials

Ownerships

Industry Comparison

Others

Overview
Chart
Forecast
MC Insights
MC Technicals
Chart Patterns
Scans
Price & Volume
Seasonality Analysis
News
Forum
Research
Deals
Corp Action
Financials
Shareholding
Financials Shareholding Peers About

Open	1,277.60
Previous Close	1,280.60
Volume	670.00
Value (Lacs)	8.56
VWAP	0.00
Beta	0.73 0.67
Mkt Cap (Rs. Cr.)	106,632

High	0.00
Low	0.00
UC Limit	1,408.60
LC Limit	1,152.60
52 Week High	1,405.90
52 Week Low	1,020.00
Face Value	1.00

All Time High	1,421.49
All Time Low	43.36
20D Avg Volume	1,833,624
20D Avg Delivery(%)	65.09
Book Value Per Share	401.97
Dividend Yield	0.63

TTM EPS See historical trend	69.16 (+8.10% YoY)
TTM PE See historical trend	18.47 (Low PE)
P/B See historical trend	3.18 (Low P/B)
Sector PE	39.89

Open	- -
Previous Close	- -
Volume	- -
Value(lacs)	- -

High	- -
Low	- -
ATP	- -
Spot	- -

OI	- -
OI Chg(Chg%)	- -
Lot Size	- -
Contracts Traded	- -

Roll Over %	- -
Roll Over Cost	- -
MWPL	- -

Advanced Chart

Click here to expand

*Delayed by 20 seconds.

Forecast

Share Price Forecast

Earnings Forecast

Actuals Estimates

ANNUALLY

(Rs.)

EPS
Net Profit
Revenue

Valuations

Consensus Recommendations

Buy
Outperform
Hold
Underperform
Sell

Hits/Misses

QUARTERLY (Rs.)

EPS
Net Profit
Revenue

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

MC Insights

Stock Score

87/100

Superior Financial Strength, High Growth Trend Stock at Attractive Valuations

Get detailed analysis with Moneycontrol Stock Insights.

Price

9.13% away from 52 week high

Financials

Piotroski Score

indicates

Industry Comparison

Market Cap - Above Median

Shareholding Pattern

Promoter holding remains unchanged at 26.64% in Sep 2025 qtr.

MC Technicals

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages

Days
5	- -
10	- -
20	- -
50	- -
100	- -
200	- -

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Moving Averages

Days

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Moving Averages

Days

CHART PATTERNS ^{Super PRO}

Price and Volume

Price Performance

1 Week		--%
1 Month		--%
3 Months		--%
YTD		--%
1 Year		--%
3 Years		--%

Volume Analysis

Volume
Delivery

SEASONALITY ANALYSIS

11 out of 17 years Dr Reddys Laboratories has given positive returns in December.

Month	Max. Positive Change(%)	Avg. Positive Change(%)	Max. Negative Change(%)	Avg. Negative Change(%)	Average Change(%)
December	15.49% (2024)	3.64%	-9.98% (2014)	-5.33%	0.47%

Seasonality Analysis

News

Stocks to Watch Today: Wakefit, Corona Remedies, Dr Reddys Labs, Wipro, Aurobindo Pharma, NLC India, Ashoka Buildcon, KEC in focus on 15 December

Dec 15 2025 01:56 AM

Trade Spotlight: How should you trade PB Fintech, Century Plyboards, Grasim, Dr Reddys Labs, Zydus Lifesciences, and others on December 12? Dec 12 2025 03:29 AM
After Dr Reddy's, Sun Pharma gets Delhi High Court nod to make, export semaglutide Dec 10 2025 01:51 PM
Delhi High Court allows Dr Reddyu2019s to make weight-loss drug for exports Dec 03 2025 09:47 AM
Pharma stocks snap 3-day losses; Lupin rises 2% after Jefferies reiterates 'Buy' call Nov 25 2025 12:14 PM

Earning + See More

Forum

Community Sentiments

50% BUY
0% SELL
50% HOLD

50%

of moneycontrol users recommend buying Dr Reddys Labs

What's your call on Dr Reddys Labs today?

Read 4 investor views

BUY SELL HOLD

angelone07
Dr Reddys Labs
Follow

9 hrs ago

Invest on your terms. With Angel One Demat at ang.elone.22.34.786839.me you can begin with small amounts, automate SIPs and grow steadily. View more

Posted by : angelone07
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Invest on your terms. With Angel One Demat at ang.elone.22.34.786839.me you can begin with small amounts, automate SIPs and grow steadily.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
Dream_Nifty8016
Dr Reddys Labs
Follow

9 hrs ago

A strong rejection has printed the first signal of the day. DreamNifty d.nifty.00.88.786839.me View more

Posted by : Dream_Nifty8016
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  A strong rejection has printed the first signal of the day. DreamNifty d.nifty.00.88.786839.me
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

3 days ago

Sponsored Post
lock in a steady 9.15% from a trusted nbfc bond 9.15% vivriti capital limited 2027 ✔️ coupon: 9.15% ✔️ rating: care a+ stable ✔️ tenor: 1y 10m (maturity: 04 nov 2027) senior secured | high-return | nbfc bond | listed add a reliable, secured nbfc bond to your portfolio and benefit from consistent yields with medium-term tenure. explore on the fixed income: https://www.thefixedincome.com/product/dvjdc1lrpt0=/1060-navi-finserv-limited-2027?utm_source=moneycontrol&utm_medium=forum&utm_campaign=product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  lock in a steady 9.15% from a trusted nbfc bond 9.15% vivriti capital limited 2027 ✔️ coupon: 9.15% ✔️ rating: care a+ stable ✔️ tenor: 1y 10m (maturity: 04 nov 2027) senior secured | high-return | nbfc bond | listed add a reliable, secured nbfc bond to your portfolio and benefit from consistent yields with medium-term tenure. explore on the fixed income: https://www.thefixedincome.com/product/dvjdc1lrpt0=/1060-navi-finserv-limited-2027?utm_source=moneycontrol&utm_medium=forum&utm_campaign=product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Broker Research

29 Oct, 2025

Deven Choksey

Reco Price 1252.60

Target Price 1140

26 Oct, 2025

Emkay Global Financial Services

Reco Price 1284.00

Target Price 1200

26 Oct, 2025

ICICI Securities

Reco Price 1284.00

Target Price 1250

29 Jul, 2025

Deven Choksey

Reco Price 1300.05

Target Price 1120

24 Jul, 2025

Prabhudas Lilladher

Reco Price 1264.85

Target Price 1270

12 May, 2025

Prabhudas Lilladher

Reco Price 1195.35

Target Price 1225

REFINITIV Report

09 Sep, 2025

Kapitalforeningen Investin Pro

Qty 581268

Price 1250.6

% Traded 0.07

09 Sep, 2025

Kapitalforeningen Pensam Invest

Qty 581268

Price 1250.6

% Traded 0.07

14 Jul, 2025

The Mtbj Ltd. As Trst For Government Pension Investment Fund Mtbj400045849

Qty 141606

Price 1254

% Traded 0.02

14 Jul, 2025

The Mtbj Ltd. As Trst For Govrnmnt Pension Invstmnt Fund Mtbj400045828

Qty 141606

Price 1254

% Traded 0.02

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

No Data For Bulk Deals.

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

Corporate Action

12 Dec, 2025 | 08:29AM

Announcement under Regulation 30 (LODR)-Press Release / Media Release
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
09 Dec, 2025 | 04:34PM

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of employee stock options
08 Dec, 2025 | 12:50PM

Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015

+ See More

Date	Agenda

+ See More

Ex-Date	Type	Dividend (Rs)

+ See More

Announcement Date	Ex-Bonus	Ratio

+ See More

Ex-Split	Old FV	New FV

+ See More

Ex-Right	Ratio	Premium

+ See More

Date	Agenda

+ See More

Financials

Consolidated
Standalone

Quarterly Annually

(Rs. Cr)

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

(Rs. Cr)

Revenue

Net Profit

BVPS

Debt to Equity

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

Shareholding

Summary

See Top Holdings

Trend

PEERS

Company Name	Price	% Chg	MCap(Cr)	TTM PE	P/B	ROE(%)	1 Yr Perform(%)	Net Profit(Rs.)	Net Sales(Rs.)	Debt to Equity
Dr Reddys Labs	1,280.60	0.10	106,882.76	18.52	3.19	16.85	2.75	5,703	32,643	0.12
Sun Pharma	1,797.10	0.20	431,184.49	41.27	5.97	15.13	-0.90	10,980	52,578	0.03
Divis Labs	6,347.50	-1.23	168,506.18	67.81	11.26	14.63	8.01	2,191	9,360	0.00
Torrent Pharma	3,782.60	-0.23	128,020.37	59.82	17.06	25.17	13.05	1,911	11,516	0.40
Cipla	1,508.00	-0.62	121,811.90	22.39	3.91	16.90	4.19	5,291	27,547	0.00

+ See More

About the Company

Dr Reddy`s Laboratories has been cateringto the needs ofthe pharmaceutical sector for over two decades. Active Pharmaceutical Ingredients (API) are their core strength, having a wide range of portfolio.The company also manufactures generic medicines with business spread across India, Russia, US and Germany as well as Proprietary Products which inlcudes NCE research, biologics business and differentiated formulations conducted in the US. Under this the company has launched Grafeel(Filgrastim) and Reditux(Rituximab).

Registered Office
- Address
  8-2-337, Road No. 3,,,Banjara Hills,
- City
  Hyderabad
- State
  Telangana
- Pin Code
  500034
- Tel. No.
  040-49002900
- Fax No.
  040-49002999
- Email
  shares@drreddys.com
- Internet
  http://www.drreddys.com
Registrars
- Address
  306, Right Wing, 3rd Floor Amrutha Ville, Opp.Yash,
- City
  Hyderabad 500082
- State
  Telangana
- Tel. No.
  040-23374967
- Fax No.
  040-23370295
- Email
  bsshyd@bigshareonline.com
- Internet
  http://www.bigshareonline.com
Management
- K Satish Reddy
  Chairman
- G V Prasad
  Co-Chairman & Manag. Director
- Claudio Albrecht
  Independent Director
- Leo Puri
  Independent Director
- Shikha Sharma
  Independent Director
+ See More
Included In
- BSE 100
  Yes
- BSE 200
  Yes
- SENSEX
  No
- CNX MIDCAP 200
  No
- NIFTY 50
  Yes
- BSE 500
  Yes
- Nifty 200
  Yes
Details
- BSE:
  500124
- NSE:
  DRREDDY
- Series
  EQ
- ISIN
  INE089A01031